Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick D Mahar

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 3, 2014
Secondary bacterial infection and empirical antibiotic use in toxic epidermal necrolysis patientsPatrick D Mahar, Jason Wasiak, Heather Cleland, et al.
Burns : Journal of the International Society for Burn Injuries|November 30, 2013
Hospital management and clinical factors associated with ophthalmic involvement in toxic epidermal necrolysisBelinda W Hii, Patrick D Mahar, Jason Wasiak, et al.
Frontiers in Medicine|February 13, 2023
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
Frontiers in Medicine|March 28, 2023
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
The Australasian Journal of Dermatology|May 14, 2024
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Considerations for paediatric patientsPeter Foley, Patrick D Mahar, Saxon D Smith, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 3, 2014
Secondary bacterial infection and empirical antibiotic use in toxic epidermal necrolysis patientsPatrick D Mahar, Jason Wasiak, Heather Cleland, et al.
Burns : Journal of the International Society for Burn Injuries|November 30, 2013
Hospital management and clinical factors associated with ophthalmic involvement in toxic epidermal necrolysisBelinda W Hii, Patrick D Mahar, Jason Wasiak, et al.
Frontiers in Medicine|February 13, 2023
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
Frontiers in Medicine|March 28, 2023
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
The Australasian Journal of Dermatology|May 14, 2024
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Considerations for paediatric patientsPeter Foley, Patrick D Mahar, Saxon D Smith, et al.
Pageof 4